Explore R&D collaboration with Japan’s top pharma firms
Department for Business and Trade (DBT) Japan are delighted to host the 5th reverse pitch webinar “Collaboration Opportunities with Japanese Pharmaceutical Companies” (9:00 BST on Tuesday 8 July), inviting the speakers from leading 5 Japanese pharmaceutical companies; Astellas Europe Ltd, Daiichi Sankyo Co Ltd, Eisai Co Ltd, Shionogi & Co Ltd and Takeda Pharmaceutical Company Limited to present their latest R&D collaboration wish list.
This webinar will provide an ideal opportunity for the UK companies / academia looking to learn the latest research priorities and collaboration structures of the leading Japanese pharmaceutical companies. There is also an opportunity to set up 1-2-1 online calls with the 5 speaker companies at a later date on request. The speakers’ contact details and how to request a meeting will become available after the webinar.
Event details
Date: Tue 8 July
Time: 9-10:30am UK Time
Location: Online by Zoom ( The link will be provided to the approved UK participants near the date.)
Webinar programme
*Q&A Moderator: Dr Ivana Poparic, Head of Life Sciences Cluster Development, MedCity / London & Partners
Registration
Pre-registration is required from here: Zoom link https://us06web.zoom.us/meeting/register/vtZdZjKYT0uL4Puz0_On1g
Key interest areas for collaboration from the speaker companies:
Astellas
Astellas is interested in emerging areas of drug discovery & development, including new biological insights, platforms, and modalities across multiple therapeutic areas.
-
Novel immuno-oncology programs and technologies
-
Targeted protein degradation programs and technologies
-
AAV gene therapy projects and technologies
-
Ophthalmology programs and technologies, including cell and gene approaches
Daiichi Sankyo
Oncology
- Research on proximity of cell membrane proteins
- Tumour specific targets/binders, and methods for exploring these targets
- Technology for the selective delivery of oligonucleotides and proteins to tumor tissues
Non-oncology
- Novel and unique chemical compounds targeting RNA and relating proteins
- Novel and unique RNA/DNA modulating technology for gene therapy
Eisai
Neurology
- Modulation of the neuro-glia-vascular unit in the brain
- Nerve regeneration without transplantation
- Brain- or cell-specific delivery systems
- Novel fluid biomarkers for neurodegenerative disease
Oncology
- New targets and concepts for the treatment of refractory cancers
- Therapeutic targets and concepts for early intervention
- Novel methodologies to make undruggable targets druggable.
Shionogi
- To find drug targets on our focus diseases other than Infectious diseases
- The targets have evidences which relates to human (clinical) evidences/data
- Both Technology to find targets from Human samples and targets themselves are OK.
- Clinical research opportunities to predict human efficacy
- Screening technology to find Hit compounds especially for “difficult” drug targets
- Low success rate of virtual screening (Inconsistencies between the result of informatics and wet experiences) and find hit compounds in wet experiences are our issues and will be interested in the companies to have “unique” screening methods
- Prediction technology on ADME/Tox in Human
- Organ in Chip, Organoid exc..
Takeda
Takeda is seeking partners with innovative therapeutic candidates and technologies in the fields of Neuroscience, Oncology, and Gastrointestinal & Inflammation.
- Neuroscience: Neurodegenerative diseases (e.g., Alzheimer’s and Parkinson’s), neuromuscular disease (e.g., ALS) and Huntington’s disease
- Oncology: Solid tumour (with preference toward lung and GI cancers), Hematologic cancer (with preference toward AML)
- Gastrointestinal & Inflammation: Inflammatory and fibrotic diseases in the skin (e.g., systemic sclerosis, atopic dermatitis) as well as the gastrointestinal system ( e.g., fibrostenotic Crohn’s disease, advanced liver fibrosis)
- Across all therapeutic areas: Novel target identification, single-cell profiling technologies, and translational patient datasets